In partnership with the Schools of Veterinary Medicine at University of Missouri and Kansas State University, the Kansas City Area Life Sciences Institute hosted a two day symposium focused on the translational and comparative aspects of human and animal medicine.
The August 28 – 29 event entitled “One Health Innovations – The Nexus of Human and Animal Medicine” was held at the Kansas City Convention Center.
One Health Advances and Successes in Comparative Medicine and Translational Research
Executive Director, One Health Commission (OHC)
Immediate Past Chair, North Carolina One Health Collaborative (NC OHC)
Adjunct Assistant Professor, Department of Clinical Sciences, College of Veterinary Medicine
NC State University
Comparative Oncology: One Health in Action
Director, Comparative Oncology Program
Center for Cancer Research, National Cancer Institute
National Institutes of Health
Designed for physicians, veterinarians, and scientists interested in research and clinical studies, the two-day Symposium featured speakers including Francis Karanu BVM, PhD, Cell Therapy Research Scientist, Likarda, LLC; David Baron, PhD, Chief Scientific Officer, Polycystic Kidney Disease Foundation; Jeffrey Bryan, DVM, MS, PhD, DACVIM, Associate Professor of Medical Oncology, University of Missouri; David Curiel, MD, PhD, Director, Biologic Therapeutics Center, Washington University in St. Louis, James Cook, DVM, PhD, William and Kathryn Allen Distinguished Professor in Orthopaedic Surgery, Director, Orthopaedic Research Division, University of Missouri, and Joseph McGuirk, DO, Professor of Medicine and Schutte/Speas Professor in Hematology-Oncology, Division Director, Division of Hematologic Malignancies and Cellular Therapeutics, Director, Blood and Marrow Transplant Program, Director, Acute Leukemia Program, University of Kansas Cancer Center, University of Kansas Medical Center
The Symposium was presented in 1 hour segments on topical areas with 3 speakers, a human health, animal health and industry/regulatory speaker followed by a panel discussion.
The agenda included topical areas such as:
- Diabetes – Islet cell transplant
- Gene Therapy – Duchenne Muscular Dystrophy
- Osteosarcoma Vaccine – Listeria Monocytogenes
- Polycystic Kidney Disease
- Gene Therapy – Melanoma
- Bioinformatic approaches to drug discovery
- Wharton Jelly – Stem Cell
Abstracts from this year’s Symposium were published in the Journal of Clinical and Translational Medicine.